Date published: 2025-12-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

V1RC3 Inhibitors

V1RC3 inhibitors represent a specialized class of chemical compounds aimed at inhibiting the activity of the V1RC3 protein. This class is characterized by its diverse chemical structures, which are meticulously designed to interact with the V1RC3 protein with high specificity. The core chemical features of these inhibitors include various heterocyclic systems, aromatic rings, and functional groups that are carefully chosen to enhance binding affinity and selectivity. These chemical entities are often engineered to fit precisely within the protein's active site or other key interaction regions, thereby disrupting the normal function of V1RC3.

The synthesis of V1RC3 inhibitors typically involves a combination of traditional organic synthesis techniques and advanced methodologies such as computational modeling and high-throughput screening. By leveraging the structural details of V1RC3, chemists can design inhibitors that exhibit optimal interactions with the target protein. This involves the precise arrangement of chemical moieties to form stable, high-affinity complexes with V1RC3. The chemical diversity within this class reflects the ongoing effort to develop compounds with varying binding profiles and functional properties, allowing for the exploration of different mechanisms of inhibition. The sophistication in the chemical design of V1RC3 inhibitors underscores the complexity of tailoring compounds to achieve specific interactions with their target protein, providing insight into the nuanced approach required for effective inhibition.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

BAPTA/AM

126150-97-8sc-202488
sc-202488A
25 mg
100 mg
$138.00
$449.00
61
(2)

A cell-permeable calcium chelator that may indirectly affect V1R11 by altering intracellular calcium levels, which are crucial for signal transduction.

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$76.00
$150.00
$725.00
$1385.00
$2050.00
73
(3)

Increases adenylate cyclase activity, raising cAMP levels and potentially modulating signaling pathways associated with V1R receptors.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$26.00
$92.00
$120.00
$310.00
$500.00
$908.00
$1821.00
46
(1)

Serves as a tyrosine kinase inhibitor, potentially impacting V1R11 signaling indirectly by inhibiting downstream signaling pathways.

KT 5720

108068-98-0sc-3538
sc-3538A
sc-3538B
50 µg
100 µg
500 µg
$97.00
$144.00
$648.00
47
(2)

A PKA inhibitor that might modulate the signaling pathways involved in V1R11 function.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

A PI3K inhibitor, potentially affecting the signaling pathways in which V1R11 participates.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

An MEK inhibitor, which could indirectly influence V1R11 activity by affecting MAPK/ERK pathways.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

A p38 MAPK inhibitor, potentially altering the signaling pathways associated with V1R11.

W-7

61714-27-0sc-201501
sc-201501A
sc-201501B
50 mg
100 mg
1 g
$163.00
$300.00
$1642.00
18
(1)

A calmodulin antagonist, which may indirectly affect V1R11 signaling by modulating calcium signaling pathways.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$182.00
$693.00
88
(1)

A ROCK inhibitor, potentially affecting cytoskeletal arrangements and indirectly influencing V1R11 signaling.